Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Dividend & Equity Income · Columbia Threadneedle

Columbia Dividend Opportunity Fund Columbia Dividend Opportunity Fund Class C (ACUIX)

Ticker ACUIX · Since 2000-06-26 · · Holdings as of May 31, 2026

Expense ratio
1.75%$175/yr per $10k
5-yr return
+10.8%annualized
1-yr return
+13.7%as of Dec 2025
Net assets
$2.5Ball share classes
Holdings
90

Bottom line

Is ACUIX a good fund? The bottom line

ACUIX is a share class of Columbia Dividend Opportunity Fund, an actively managed dividend & equity income mutual fund from Columbia Threadneedle.

Annual fees run 1.75% — about $175 a year on every $10,000 invested, more expensive than 93% of dividend & equity income funds we track.

It returned +13.7% over one year, +10.8% a year over five years, +9.4% a year over ten (as of Dec 31, 2025, per its prospectus).

With $2.5 billion in net assets and 90 holdings, its largest position is Cisco Systems Inc (3.6%) and the top 10 make up 25.7% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.75%)
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What ACUIX invests in

Columbia Dividend Opportunity Fund (the Fund)seeks to provide shareholders with a high level of current income.

The Funds assets primarily are invested in equity securities. Under normal circumstances , the Fund invests at least 80% of its net assets ( plus the amount of any borrowings for investment purposes) in dividend-paying common and preferred stocks. The selection of dividend-paying stocks is the primary decision in building the investment portfolio. The Fund invests principally in securities of companies believed to be attractively valued and to have the potential for long-term growth. The Fund may invest in companies that have market capitalizations of any size. The Fund may at times emphasize one or more sectors in selecting its investments . As of its most recent fiscal year end , the Fund had an investment emphasis in the financials sector. The Fund may invest up to 25% of its net assets in foreign investments.

From the fund's prospectus (filed Sep 24, 2026).

ACUIX performance

Average annual total returns
1 yr5 yr10 yr
ACUIX+13.7%+10.8%+9.4%
Dividend & Equity Income median+14.6%+10.1%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full ACUIX performance history →

What ACUIX costs

On a $10,000 investment, ACUIX's 1.75% expense ratio costs about $175 a year. The prospectus estimates $1,864 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.

See the full ACUIX fee table →

ACUIX top 10 holdings

#Holding% of fund
1Cisco Systems Inc3.60%
2Exxon Mobil Corp3.35%
3JPMorgan Chase & Co2.91%
4Goldman Sachs Group Inc/The2.80%
5Johnson & Johnson2.60%
6International Business Machines Corp2.30%
7Philip Morris International Inc2.17%
8Chevron Corp2.09%
9AbbVie Inc1.97%
10Merck & Co Inc1.90%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 25.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to ACUIX

More funds like ACUIX →

ACUIX FAQ

What is the expense ratio of ACUIX?
ACUIX's expense ratio is 1.75%, which works out to about $175 a year for every $10,000 invested. The prospectus estimates total costs of $1,864 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is ACUIX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.75%); 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does ACUIX hold?
ACUIX's largest holdings are Cisco Systems Inc (3.6%), Exxon Mobil Corp (3.3%), JPMorgan Chase & Co (2.9%), Goldman Sachs Group Inc/The (2.8%), Johnson & Johnson (2.6%). It holds 90 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is ACUIX's 5-year return?
ACUIX returned +10.8% a year over the five years ending Dec 31, 2025, and +9.4% a year over ten years. Past performance does not guarantee future results.
Does ACUIX have a sales load?
No. ACUIX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages ACUIX?
ACUIX is offered by Columbia Threadneedle through Columbia Funds Series Trust II.